Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Dec;36(12):2821–2824. doi: 10.1128/aac.36.12.2821

Optimal dosing of trimethoprim-sulfamethoxazole when used with loperamide to treat traveler's diarrhea.

C D Ericsson 1, I Nicholls-Vasquez 1, H L DuPont 1, J J Mathewson 1
PMCID: PMC245552  PMID: 1482152

Abstract

To explore the optimal dosing regimen for trimethoprim-sulfamethoxazole (TMP-SMX) when used in combination with loperamide to treat traveler's diarrhea, 190 U.S. adults with acute diarrhea were enrolled in a double-blind, randomized trial in Guadalajara, Mexico. All patients received loperamide (4-mg loading dose; 2 mg after each loose stool, not to exceed 16 mg/day for 3 days) and were randomized to receive a 3-day course of TMP-SMX (160:800 mg twice daily for six doses) (group A), a single large dose of TMP-SMX (320:1,600 mg) (group B), or a large loading dose (320:1,600 mg) followed by standard doses for 3 days (160:800 mg twice daily for five doses) (group C). Patients in group C responded best (P < 0.01), with 75% of subjects recovered from diarrhea in 12 h compared with 34 h (group A) and 33 h (group B). Similar differences in favor of group C were noted in the subset of patients who presented with moderate to severe diarrhea. On average, patients in group C took significantly (P < 0.05) less loperamide (1.2 mg) after the 4-mg loading dose compared with patients in group A (2.4 mg) or group B (2.0 mg). We conclude that the most efficacious treatment of traveler's diarrhea in the interior of Mexico is to take loperamide in usual doses to control symptoms in combination with a single large dose of TMP-SMX, which should then be continued for 3 days in standard doses.

Full text

PDF
2821

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bandres J. C., Mathewson J. J., Ericsson C. D., Dupont H. L. Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico. Am J Med Sci. 1992 May;303(5):289–291. doi: 10.1097/00000441-199205000-00003. [DOI] [PubMed] [Google Scholar]
  2. DuPont H. L., Ericsson C. D., Johnson P. C., Bitsura J. A., DuPont M. W., de la Cabada F. J. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA. 1987 Mar 13;257(10):1347–1350. [PubMed] [Google Scholar]
  3. DuPont H. L., Ericsson C. D., Mathewson J. J., DuPont M. W. Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study. Antimicrob Agents Chemother. 1992 Jan;36(1):87–91. doi: 10.1128/aac.36.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DuPont H. L., Ericsson C. D., Reves R. R., Galindo E. Antimicrobial therapy for travelers' diarrhea. Rev Infect Dis. 1986 May-Jun;8 (Suppl 2):S217–S222. doi: 10.1093/clinids/8.supplement_2.s217. [DOI] [PubMed] [Google Scholar]
  5. Ericsson C. D., DuPont H. L., Johnson P. C. Nonantibiotic therapy for travelers' diarrhea. Rev Infect Dis. 1986 May-Jun;8 (Suppl 2):S202–S206. doi: 10.1093/clinids/8.supplement_2.s202. [DOI] [PubMed] [Google Scholar]
  6. Ericsson C. D., DuPont H. L., Mathewson J. J., West M. S., Johnson P. C., Bitsura J. A. Treatment of traveler's diarrhea with sulfamethoxazole and trimethoprim and loperamide. JAMA. 1990 Jan 12;263(2):257–261. [PubMed] [Google Scholar]
  7. Ericsson C. D., Patterson T. F., Dupont H. L. Clinical presentation as a guide to therapy for travelers' diarrhea. Am J Med Sci. 1987 Aug;294(2):91–96. doi: 10.1097/00000441-198708000-00006. [DOI] [PubMed] [Google Scholar]
  8. Kozicki M., Steffen R., Schär M. 'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea? Int J Epidemiol. 1985 Mar;14(1):169–172. doi: 10.1093/ije/14.1.169. [DOI] [PubMed] [Google Scholar]
  9. Mathewson J. J., Johnson P. C., DuPont H. L., Morgan D. R., Thornton S. A., Wood L. V., Ericsson C. D. A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J Infect Dis. 1985 Mar;151(3):471–475. doi: 10.1093/infdis/151.3.471. [DOI] [PubMed] [Google Scholar]
  10. Petruccelli B. P., Murphy G. S., Sanchez J. L., Walz S., DeFraites R., Gelnett J., Haberberger R. L., Echeverria P., Taylor D. N. Treatment of traveler's diarrhea with ciprofloxacin and loperamide. J Infect Dis. 1992 Mar;165(3):557–560. doi: 10.1093/infdis/165.3.557. [DOI] [PubMed] [Google Scholar]
  11. Steffen R., Heusser R., DuPont H. L. Prevention of travelers' diarrhea by nonantibiotic drugs. Rev Infect Dis. 1986 May-Jun;8 (Suppl 2):S151–S159. doi: 10.1093/clinids/8.supplement_2.s151. [DOI] [PubMed] [Google Scholar]
  12. Taylor D. N., Sanchez J. L., Candler W., Thornton S., McQueen C., Echeverria P. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann Intern Med. 1991 May 1;114(9):731–734. doi: 10.7326/0003-4819-114-9-731. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES